Navigation Links
Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award

BOSTON, Sept. 9, 2011 /PRNewswire/ -- Mass High Tech has selected Greenberg Traurig shareholder Jennifer A. Camacho to be a recipient of its 2011 All-Stars Award, one that recognizes 15 driven and influential leaders of New England's innovation economy.  

Camacho will be recognized for her wide range of experience in and contribution to the life sciences sector.  As a patent attorney, she represents pharmaceutical and biotechnology clients. Camacho brings a real-world perspective to client representation from her tenure as chief patent counsel, vice president of intellectual property and general counsel at a venture-backed start-up company in the emerging field of synthetic biology and DNA synthesis.  She is a founding team member for the International Consortium for Polynucleotide Synthesis, Inc., and currently serves on the board of directors for the Center for Policy on Emerging Technologies in Washington, D.C.  In addition,  Camacho serves as a judge and mentor for the MassChallenge, Inc. annual startup competition and accelerator program.

"The 2011 All-Stars have a proven record in leading not only their own companies but in helping their industry thrive and in guiding entrepreneurs who are building the successful tech companies of tomorrow," said Mass High Tech publisher Doug Banks.  "The companies and industries that they have helped to build are the basis of the economic engine that provides jobs and spawns innovation throughout New England and the United States."

Honorees will be profiled in a special report on and recognized at an evening awards celebration and networking reception on Wednesday, November 16th, at the House of Blues in Boston.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1,800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit

SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Mymetics Corporation Important Shareholders Information Conference Call
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Chromos announces shareholder approval of Arrangement
7. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
8. ARIUS sale approved by shareholders
9. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
10. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
11. Insmed to Seek Shareholder Approval for Reverse Split
Post Your Comments:
(Date:10/12/2015)... SAN FRANCISCO , October 12, 2015 ... reach USD 6.49 billion by 2022, according to a new ... can be attributed to rise in incidence of oncology diseases ... detection market is expected to reach USD 6.49 billion ... Research, Inc. This growth in demand can be attributed to ...
(Date:10/12/2015)... CAESAREA, Israel , October 12, 2015 ... of the Dario™ Diabetes Management Solution, today announced its ... a patient case study at MobiHealth,s 5th EAI ... Focused on, "Transforming healthcare through innovations in mobile and ... London, England from October 14 - ...
(Date:10/12/2015)... ... ... NeuMedics Inc., is a specialty biopharmaceutical company focused on identifying and developing ... administered as an eye drop, announced today it has been selected to present at ... October 25th to October 28th at The Cleveland Clinic, Cleveland, Ohio. The purpose ...
(Date:10/10/2015)... , 10. Oktober, 2015 Am ... (Abgeordnete der Demokratischen Partei für Kalifornien) ihre Würdigung ... 17. Oktober) in die Aufzeichnungen des Kongresses eintragen ... Protein Therapeutics Association (PPTA) und ihren Mitgliedsunternehmen ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
Breaking Biology Technology:
(Date:9/28/2015)... , September 28, 2015 According ... (Hardware & Software), Product (Scanner & Others), Application (Access ... Defense, & Others) & Geography Global - Forecast to ... to reach USD 3627.90 Million by 2020, at a ... Browse 65 market data T ables and ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a market ... its award winning and latest technology in Booth #602 ... California . EyeLock,s iris authentication technology ... unmatched biometric accuracy, making it the most proven way ... uses video technology to deliver a fast and friendly ...
(Date:9/10/2015)... Report Details Emerging Biological ... and Revenue Prospects to Help You Stay Ahead ... new drug classes? Get the latest technological and ... market data and industry knowledge, benefitting your influence. ... and sales predictions. Visiongain,s new study reveals ...
Breaking Biology News(10 mins):